The study will also explore the long-term efficacy and safety of MabThera in this patient population, as well as the rate of molecular remission, a predictor of long term outcome in CLL.

• 研究还将探索美罗华在这类患者人群中的长期疗效和安全性，以及预测CLL长期结果的分子水平缓解率。